Mereana Therapeutics

Mereana Therapeutics is a pre-clinical stage biotechnology company focused on the development of circular RNA (circRNA) therapeutics. The company aims to leverage the unique properties of circRNA, such as increased stability and durability of protein expression, to create a new class of medicines for genetic and chronic diseases. Founded by industry veterans from Alnylam and Moderna, Mereana is building a proprietary platform to optimize RNA circularization and delivery. The company is headquartered in Cambridge, Massachusetts, and is currently advancing its early-stage discovery pipeline. By overcoming the limitations of linear mRNA, Mereana seeks to expand the reach of RNA-based therapies to a broader range of clinical applications.